|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2068880 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07820235.5 |
| Date of filing the European patent application | 2007-09-14 | |
| (97) | Date of publication of the European application | 2009-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2012-04-11 |
| (46) | Date of publication of the claims translation | 2012-08-27 |
| (86) | Number | PCT/EP2007/059735 |
| Date | 2007-09-14 |
| (87) | Number | WO 2008/034776 |
| Date | 2008-03-27 |
| (30) | Number | Date | Country code |
| 06120856 | 2006-09-18 | EP | |
| 07101505 | 2007-01-31 | EP |
| (72) |
SOLCA, Flavio, AT
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Vėžio, turinčio EGFR mutacijų, gydymo būdas |
| METHOD FOR TREATING CANCER HARBORING EGFR MUTATIONS |
| Payment date | Validity (years) | Amount | |
| 2013-08-23 | 7 | 560.00 LTL |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2014-05-13 |